AAAAAA
Results: 1-25/29
Authors:
KAPPE R
LEVITZ S
HARRISON TS
RUHNKE M
AMPEL NM
JUSTNUBLING G
Citation: R. Kappe et al., RECENT ADVANCES IN CRYPTOCOCCOSIS, CANDIDIASIS AND COCCIDIOIDOMYCOSISCOMPLICATING HIV-INFECTION, MEDICAL MYCOLOGY, 36, 1998, pp. 207-215
Authors:
HEGENER P
TROKE PF
FATKENHEUER G
DIEHL V
RUHNKE M
Citation: P. Hegener et al., TREATMENT OF FLUCONAZOLE-RESISTANT CANDIDIASIS WITH VORICONAZOLE IN PATIENTS WITH AIDS, AIDS, 12(16), 1998, pp. 2227-2228
Authors:
KUHN W
RUHNKE M
Citation: W. Kuhn et M. Ruhnke, INTRAPERITONEAL COMPLETE SPONTANEOUS REMI SSION OF A SEROUS BORDERLINE TUMOR OF THE OVARY STAGE-IIIC (LYMPH-NODE IMPLANTS RESIDUAL TUMOR GREATER-THAN-2 CM), Geburtshilfe und Frauenheilkunde, 58(4), 1998, pp. 204-207
Authors:
KUHN W
RUHNKE M
COUMBOS A
WILLRODT RG
UNVERRICHT C
DEUTSCHMANN C
Citation: W. Kuhn et al., DNA CYTOMETRY IN ABNORMAL PAP-SMEARS OF T HE CERVIX, Geburtshilfe und Frauenheilkunde, 58(1), 1998, pp. 38-43
Authors:
SCHMIDT WA
VOLKER L
ZACHER J
GURSCHE A
SCHLAFKE M
RUHNKE M
SATTLER H
GROMNICAIHLE EJ
Citation: Wa. Schmidt et al., COLOR DUPLEX ULTRASONOGRAPHY TO DETECT PANNUS IN KNEE-JOINT EFFUSION, Arthritis and rheumatism, 41(9), 1998, pp. 102-102
Authors:
SCHNEIDER U
RUHNKE M
DELECLUSE HJ
HUHN D
Citation: U. Schneider et al., TREATMENT OF EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN HIV-INFECTED PATIENTS WITH FOSCARNET, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 97-97
Authors:
TRAUTMANN M
RUHNKE M
RUKAVINA T
HELD TK
CROSS AS
MARRE R
WHITFIELD C
Citation: M. Trautmann et al., O-ANTIGEN SEROEPIDEMIOLOGY OF KLEBSIELLA CLINICAL ISOLATES AND IMPLICATIONS FOR IMMUNOPROPHYLAXIS OF KLEBSIELLA INFECTIONS, Clinical and diagnostic laboratory immunology, 4(5), 1997, pp. 550-555
Authors:
RUHNKE M
BEYER J
Citation: M. Ruhnke et J. Beyer, ANTIMYCOTIC PROPHYLAXIS IN NEUTROPENIC AN D IMMUNOSUPPRESSED PATIENTS, Medizinische Klinik, 92(1), 1997, pp. 28-36
Authors:
BOCKER W
DECKER T
RUHNKE M
SCHNEIDER W
Citation: W. Bocker et al., DUCTAL HYPERPLASIA AND DUCTAL CARCINOMA I N-SITU, Der Pathologe, 18(1), 1997, pp. 3-18
Authors:
DECKER T
RUHNKE M
SCHNEIDER W
Citation: T. Decker et al., STANDARDIZED PATHOLOGICAL EXAMINATION OF BREAST BIOPSY SPECIMENS, Der Pathologe, 18(1), 1997, pp. 53-59
Authors:
RUHNKE M
SCHMIDTWESTHAUSEN A
TRAUTMANN M
Citation: M. Ruhnke et al., IN-VITRO ACTIVITIES OF VORICONAZOLE (UK-109,496) AGAINST FLUCONAZOLE-SUSCEPTIBLE AND FLUCONAZOLE-RESISTANT CANDIDA-ALBICANS ISOLATES FROM ORAL CAVITIES OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 575-577
Authors:
DAUTZENBERG B
OLLIARO P
RUF B
ESPOSITO R
OPRAVIL M
HOY JF
ROZENBAUM W
CAROSI GP
MICOUD M
LAGE M
PIROTTA N
SASSELLA D
COULAUD JP
VILDE JL
GENTILINI M
CAUBARRERE I
CAQUET R
WEINBRECK P
LEBEAU B
HUMBERT G
MODAI J
ARMENGAUD M
DUFFAUT M
DUJARDIN P
DELLAMONICA P
MOUTON Y
GALLAIS H
GASTAUD JA
GENIAUX M
SUERI L
BARNI C
CALIGARIS S
ELHAMAD I
ERRANTE I
MORONI M
FRANZETTI F
CARGNEL A
DEDIVITIIS GF
MARONE P
PASTICCI MB
HELM EB
RUHNKE M
SCHURMANN D
SCHULER W
ERCKENBRECHT I
HEISE W
BROCKMEYER N
DIETRICH M
JONES P
GROSSET J
PENATI V
MAUCH H
SALFINGER M
DWYER B
GILBERT L
DESLANDES JY
DOLFI L
GLANZMANN I
HARRIS M
HERCEG R
LANDI V
MORELLI P
SCOLA E
WEINIG S
KUNIN MC
CARBON NC
GRASSI G
NORRBY SR
POCOCK SJ
Citation: B. Dautzenberg et al., RIFABUTIN VERSUS PLACEBO IN COMBINATION WITH 3 DRUGS IN THE TREATMENTOF NONTUBERCULOUS MYCOBACTERIAL INFECTION IN PATIENTS WITH AIDS, Clinical infectious diseases, 22(4), 1996, pp. 705-708
Authors:
RUHNKE M
SCHMIDTWESTHAUSEN A
TRAUTMANN M
Citation: M. Ruhnke et al., COMPARISON OF 3 ANTIFUNGAL SUSCEPTIBILITY TESTING METHODS FOR THE IN-VITRO TESTING OF CANDIDA ISOLATES FROM PATIENTS WITH HIV-INFECTION, Mycoses, 39, 1996, pp. 47-50
Authors:
RUHNKE M
SCHNEIDER U
HEGENER P
Citation: M. Ruhnke et al., EFFICACY OF UK-109,496 IN FLUCONAZOLE-RESISTANT CANDIDA ESOPHAGITIS, AIDS, 10, 1996, pp. 103-103
Authors:
RUHNKE M
SCHMIDTWESTHAUSEN A
ENGELMANN E
TRAUTMANN M
Citation: M. Ruhnke et al., COMPARATIVE-EVALUATION OF 3 ANTIFUNGAL SUSCEPTIBILITY TEST METHODS FOR CANDIDA-ALBICANS ISOLATES AND CORRELATION WITH RESPONSE TO FLUCONAZOLE THERAPY, Journal of clinical microbiology, 34(12), 1996, pp. 3208-3211
Authors:
TRAUTMANN M
RUHNKE M
BORNER K
WAGNER J
KOEPPE P
Citation: M. Trautmann et al., PHARMACOKINETICS OF SPARFLOXACIN AND SERUM BACTERICIDAL ACTIVITY AGAINST PNEUMOCOCCI, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 776-779
Authors:
RUHNKE M
YEATES RA
PFAFF G
SARNOW E
HARTMANN A
TRAUTMANN M
Citation: M. Ruhnke et al., SINGLE-DOSE PHARMACOKINETICS OF FLUCONAZOLE IN PATIENTS WITH LIVER-CIRRHOSIS, Journal of antimicrobial chemotherapy, 35(5), 1995, pp. 641-647
Authors:
JABLONOWSKI H
ARASTEH K
STASZEWSKI S
RUF B
STELLBRINK HJ
SCHRAPPE M
STOEHR A
HAASE W
SCHOMAKER U
ROTHE BV
THOMIS J
STILLE W
LAGE M
POHLE HD
ALBRECHT H
FATKENHEUER G
DIEHL V
PLETTENBERG A
SCHUSTER D
KNECHTEN H
RUHNKE M
ALEXANDER M
SCHWANDER S
DIETRICH M
RUBBERT A
KALDEN JR
EMMINGER C
EICHENLAUB D
SCHEDEL I
DEICHER H
HEHLMANN R
RASOKAT H
DENGLER HJ
HOFFKEN G
BROCKHAUS W
ZIDEK W
WILKE G
FISCHER JT
ULMER A
PETZOLDT D
PEES HW
ZANGERLE R
DUNCKER D
KRIPPNER H
RIEGER T
KERN P
Citation: H. Jablonowski et al., A DOSE COMPARISON STUDY OF DIDANOSINE IN PATIENTS WITH VERY ADVANCED HIV-INFECTION WHO ARE INTOLERANT TO OR CLINICALLY DETERIORATE ON ZIDOVUDINE, AIDS, 9(5), 1995, pp. 463-469
Authors:
LISCHEWSKI A
RUHNKE M
TENNAGEN I
SCHONIAN G
MORSCHHAUSER J
HACKER J
Citation: A. Lischewski et al., MOLECULAR EPIDEMIOLOGY OF CANDIDA ISOLATES FROM AIDS PATIENTS SHOWINGDIFFERENT FLUCONAZOLE RESISTANCE PROFILES, Journal of clinical microbiology, 33(3), 1995, pp. 769-771
Authors:
RUHNKE M
TENNAGEN I
ENGELMANN E
Citation: M. Ruhnke et al., CORRELATION BETWEEN ANTIFUNGAL SUSCEPTIBI LITY TESTING AND TYPING OF CANDIDA-ALBICANS ISOLATES FROM PATIENTS WITH AIDS AND CHRONIC RECURRENT OROPHARYNGEAL CANDIDOSIS, Mycoses, 37, 1994, pp. 60-63
Authors:
YEATES RA
RUHNKE M
PFAFF G
HARTMANN A
TRAUTMANN M
SARNOW E
Citation: Ra. Yeates et al., THE PHARMACOKINETICS OF FLUCONAZOLE AFTER A SINGLE INTRAVENOUS DOSE IN AIDS PATIENTS, British journal of clinical pharmacology, 38(1), 1994, pp. 77-79
Authors:
TRAUTMANN M
WIEDECK H
RUHNKE M
OETHINGER M
MARRE R
Citation: M. Trautmann et al., TEICOPLANIN - 10 YEARS OF CLINICAL-EXPERIENCE, Infection, 22(6), 1994, pp. 430-436
Authors:
RUHNKE M
TRAUTMANN M
Citation: M. Ruhnke et M. Trautmann, RECENT TRENDS IN ANTIMYCOTIC CHEMOTHERAPY, Infection, 22(2), 1994, pp. 117-117
Authors:
PLETTENBERG A
STOEHR A
HOFFKEN G
BERGS C
TSCHECHNE B
RUHNKE M
HEISE W
DIECKMANN S
MEIGEL W
Citation: A. Plettenberg et al., FLUCONAZOLE THERAPY OF ORAL CANDIDIASIS IN HIV-INFECTED PATIENTS - RESULTS OF A MULTICENTER STUDY, Infection, 22(2), 1994, pp. 118-123
Authors:
RUHNKE M
EIGLER A
ENGELMANN E
GEISELER B
TRAUTMANN M
Citation: M. Ruhnke et al., CORRELATION BETWEEN ANTIFUNGAL SUSCEPTIBILITY TESTING OF CANDIDA ISOLATES FROM PATIENTS WITH HIV-INFECTION AND CLINICAL-RESULTS AFTER TREATMENT WITH FLUCONAZOLE, Infection, 22(2), 1994, pp. 132-136